0,936  0,000  GABA C receptor agonist
0,907  0,001  Glutamate decarboxylase inhibitor
0,862  0,004  Eye irritation, high
0,851  0,002  Alcohol oxidase inhibitor
0,805  0,005  GST A substrate
0,782  0,002  Porphobilinogen synthase inhibitor
0,740  0,002  Glutamate dehydrogenase inhibitor
0,738  0,005  Platelet antagonist
0,740  0,009  Radioprotector
0,725  0,002  GABA aminotransferase inhibitor
0,703  0,004  Superoxide dismutase inhibitor
0,690  0,005  Skin irritative effect
0,685  0,004  Flavin-containing monooxygenase substrate
0,695  0,016  Teratogen
0,678  0,003  FMO3 substrate
0,669  0,012  Chemoprotective
0,670  0,017  Embryotoxic
0,662  0,017  TNF expression inhibitor
0,631  0,003  Growth hormone agonist
0,628  0,004  Phospholipase C inhibitor
0,634  0,009  Interleukin antagonist
0,630  0,006  Antimutagenic
0,632  0,015  Aldehyde oxidase inhibitor
0,630  0,032  Caspase 9 stimulant
0,610  0,012  Stroke treatment
0,605  0,013  Analeptic
0,584  0,004  Interleukin 2 agonist
0,577  0,003  Tyrosine 3 hydroxylase inhibitor
0,574  0,006  Antihypoxic
0,571  0,003  5 Hydroxytryptamine uptake stimulant
0,579  0,018  Antithrombotic
0,563  0,004  Alpha-N-acetylglucosaminidase inhibitor
0,579  0,021  Cholesterol antagonist
0,570  0,013  Apoptosis antagonist
0,559  0,010  FMO1 substrate
0,563  0,014  Histamine release inhibitor
0,565  0,016  Antipruritic, allergic
0,553  0,006  Interleukin agonist
0,560  0,015  UGT1A9 substrate
0,546  0,003  Coagulant
0,547  0,009  Angiogenesis stimulant
0,556  0,019  5 Hydroxytryptamine release stimulant
0,550  0,015  Cardiovascular analeptic
0,554  0,022  Respiratory analeptic
0,546  0,015  GABA C receptor rho-3 antagonist
0,529  0,003  Arylamine N-Acetyltransferase substrate
0,539  0,016  Ulceration
0,523  0,002  GABA C receptor antagonist
0,539  0,021  Carcinogenic
0,526  0,009  Psychostimulant
0,517  0,004  GST P1-1 substrate
0,514  0,002  Ferrochelatase inhibitor
0,514  0,005  Thrombolytic
0,509  0,002  Triose-phosphate isomerase inhibitor
0,514  0,009  Peroxidase inhibitor
0,502  0,005  Antidote
0,500  0,003  Succinate dehydrogenase inhibitor
0,527  0,031  CYP2C9 substrate
0,493  0,002  Carbamoyl phosphate synthetase inhibitor
0,488  0,003  Ornithine carbamoyltransferase inhibitor
0,503  0,020  Cytostatic
0,506  0,025  Antihypercholesterolemic
0,490  0,011  Myocardial infarction treatment
0,490  0,012  UGT2B4 substrate
0,500  0,023  Immunomodulator
0,483  0,009  Radiosensitizer
0,496  0,023  Cardioprotectant
0,489  0,022  Antiischemic
0,471  0,010  Anesthetic general
0,493  0,033  Atherosclerosis treatment
0,461  0,003  Excitatory amino acid transporter EAAC1 inhibitor
0,459  0,002  NMDA receptor agonist
0,469  0,015  UGT1A6 substrate
0,458  0,005  Antipruritic, non-allergic
0,455  0,004  Carcinogenic, group 1
0,472  0,024  NOS3 expression inhibitor
0,474  0,029  CYP2D6 substrate
0,482  0,038  5 Hydroxytryptamine release inhibitor
0,446  0,005  Peptidyltransferase inhibitor
0,446  0,005  Aldehyde dehydrogenase inhibitor
0,454  0,013  Platelet aggregation inhibitor
0,492  0,053  Cyclophilin D inhibitor
0,492  0,053  Antidiabetic
0,442  0,003  Histidine decarboxylase inhibitor
0,436  0,003  Phenylalanine 4-hydroxylase inhibitor
0,466  0,034  Immunostimulant
0,439  0,008  Antineoplastic antimetabolite
0,431  0,004  Antineoplastic, alkylator
0,461  0,037  Vasodilator, peripheral
0,443  0,020  DNA damaging
0,441  0,019  Antidiabetic symptomatic
0,421  0,002  Fumarate hydratase inhibitor
0,436  0,017  Insulysin inhibitor
0,432  0,014  Anticoagulant
0,429  0,012  UGT1A4 substrate
0,427  0,015  Wound healing agent
0,420  0,011  Antiseptic
0,411  0,003  Adenylate kinase inhibitor
0,413  0,006  Pancreatic disorders treatment
0,417  0,014  Septic shock treatment
0,421  0,019  Acute neurologic disorders treatment
0,414  0,013  Muscle relaxant
0,397  0,002  GABA C receptor rho-1 antagonist
0,410  0,016  UGT1A1 substrate
0,408  0,015  Abortion inducer
0,395  0,002  Aconitate hydratase inhibitor
0,394  0,002  GABA B receptor agonist
0,405  0,015  Sodium/bile acid cotransporter inhibitor
0,415  0,027  Proliferative diseases treatment
0,391  0,004  Hematopoietic
0,435  0,051  Immunosuppressant
0,392  0,013  Antihypotensive
0,399  0,020  Antiulcerative
0,382  0,003  Phosphofructokinase-1 inhibitor
0,449  0,072  Antiarthritic
0,396  0,022  DNA synthesis inhibitor
0,407  0,035  CTGF expression inhibitor
0,374  0,004  Antispirochetal
0,414  0,046  Bone diseases treatment
0,379  0,011  Skeletal muscle relaxant
0,372  0,004  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,395  0,028  Hypoglycemic
0,372  0,007  CNS active muscle relaxant
0,395  0,031  Mutagenic
0,374  0,011  Antialcoholic
0,367  0,005  Aminopeptidase B inhibitor
0,389  0,029  Antipyretic
0,365  0,005  SULT1A3 substrate
0,423  0,067  Antibacterial
0,415  0,059  CYP3A4 substrate
0,385  0,029  Antiglaucomic
0,360  0,011  Protein kinase stimulant
0,359  0,011  Hemostatic
0,392  0,043  Antihypertensive
0,372  0,024  Antineoplastic (lymphocytic leukemia)
0,376  0,031  Cardiodepressant
0,344  0,003  Argininosuccinate synthase inhibitor
0,343  0,005  Carbonic anhydrase III inhibitor
0,380  0,042  Vasodilator, coronary
0,364  0,028  Antineoplastic (endocrine cancer)
0,357  0,022  Antiparkinsonian, rigidity relieving
0,349  0,018  UGT2B7 substrate
0,350  0,023  GST M1-1 substrate
0,370  0,046  CYP1A2 substrate
0,370  0,047  Spasmolytic
0,337  0,014  Gastrin inhibitor
0,335  0,013  Muscular dystrophy treatment
0,326  0,004  Antiviral (West Nile virus)
0,337  0,018  Diuretic
0,336  0,018  Antianorexic
0,323  0,004  GP IIb/IIIa receptor antagonist
0,327  0,011  Alkylator
0,325  0,009  Chelator
0,320  0,004  Toll-Like receptor 2 antagonist
0,328  0,013  Sepsis treatment
0,329  0,017  Carcinogenic, group 3
0,317  0,005  Antifungal (Cryptococcus)
0,318  0,007  Antianemic
0,326  0,014  Bone formation stimulant
0,357  0,046  Calcium channel activator
0,323  0,013  CYP2B6 inhibitor
0,310  0,001  Lysine carboxypeptidase inhibitor
0,314  0,005  Carbonic anhydrase VI inhibitor
0,320  0,012  Corneal wound healing stimulator
0,310  0,004  Photosensitizer
0,311  0,005  Catalase inhibitor
0,309  0,004  Raynaud's phenomenon treatment
0,318  0,013  Insulin sensitizer
0,309  0,005  Alcohol dehydrogenase inhibitor
0,342  0,039  Antineoplastic (small cell lung cancer)
0,346  0,044  Sensitization
0,339  0,036  Vascular (periferal) disease treatment
0,317  0,019  Macular degeneration treatment
0,307  0,010  Cell adhesion inhibitor
0,311  0,013  Neurotensin receptor agonist
0,316  0,019  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,323  0,027  Platelet adhesion inhibitor
0,299  0,003  Adenylate cyclase stimulant
0,314  0,019  UGT1A3 substrate
0,298  0,003  Ornithine decarboxylase inhibitor
0,307  0,013  Adenylate cyclase inhibitor
0,299  0,007  Uterine stimulant
0,295  0,004  NMDA 2C receptor antagonist
0,292  0,004  NAT2 substrate
0,301  0,013  Glutathione S-transferase substrate
0,296  0,008  Histone deacetylase SIRT1 inhibitor
0,334  0,049  Antidiabetic (type 2)
0,289  0,003  Biliverdin reductase inhibitor
0,299  0,014  Phospholipase A2 inhibitor
0,288  0,003  Antidote, heavy metal
0,350  0,067  Antiallergic
0,302  0,020  Hair growth stimulant
0,287  0,007  Retinoprotector
0,285  0,007  UGT2B10 substrate
0,331  0,056  Antiosteoporotic
0,331  0,056  CYP2C19 substrate
0,281  0,008  Age-related macular degeneration treatment
0,337  0,065  Hepatic disorders treatment
0,335  0,063  AR expression inhibitor
0,285  0,014  Insulin secretagoues
0,303  0,035  UDP-glucuronosyltransferase substrate
0,272  0,004  Folate antagonist
0,270  0,003  Glycine receptor agonist
0,275  0,008  NMDA receptor antagonist
0,275  0,010  Expectorant
0,292  0,028  VCAM1 expression inhibitor
0,287  0,024  Lipocortins synthesis antagonist
0,274  0,012  Cell wall synthesis inhibitor
0,281  0,020  Antiparkinsonian, tremor relieving
0,279  0,018  Interleukin 6 antagonist
0,310  0,050  Cytotoxic
0,265  0,005  Mucolytic
0,312  0,053  NOS2 expression inhibitor
0,305  0,046  Vasodilator
0,263  0,005  Antirickettsial
0,287  0,031  Non-steroidal antiinflammatory agent
0,269  0,014  Antifungal enhancer
0,296  0,042  Anticonvulsant
0,275  0,022  Amylase inhibitor
0,258  0,005  Integrin antagonist
0,259  0,008  NADH dehydrogenase inhibitor
0,281  0,030  Neuropeptide Y2 antagonist
0,264  0,013  Shock treatment
0,332  0,082  Transcription factor NF kappa B inhibitor
0,259  0,011  Antiviral (Poxvirus)
0,257  0,010  Catenin beta inhibitor
0,373  0,126  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,257  0,011  Carbonic anhydrase XV inhibitor
0,292  0,047  Amyloid beta aggregation inhibitor
0,261  0,016  Antihyperlipoproteinemic
0,279  0,035  DNA methylase inhibitor
0,245  0,005  Electrolyte absorption antagonist
0,278  0,039  Sedative
0,247  0,012  Antiviral (Ebola)
0,310  0,075  Antifungal
0,239  0,005  Aminopeptidase I inhibitor
0,243  0,010  Nav1.4 sodium channel blocker
0,244  0,011  SULT1A1 substrate
0,314  0,081  ICAM1 expression inhibitor
0,234  0,003  AMPA 4 receptor antagonist
0,238  0,009  Aminoacyl-tRNA synthetase inhibitor
0,234  0,005  Prolactin inhibitor
0,233  0,004  Glutamate release inhibitor
0,231  0,003  Glutamate (mGluR3) antagonist
0,266  0,038  Myocardial ischemia treatment
0,246  0,019  Pulmonary hypertension treatment
0,230  0,005  Interferon agonist
0,233  0,007  Interleukin 8 antagonist
0,263  0,040  Hepatoprotectant
0,226  0,004  Paget's disease treatment
0,247  0,026  Cystic fibrosis treatment
0,259  0,037  Antianginal
0,227  0,006  Carbonic anhydrase stimulant
0,291  0,071  Lipoprotein disorders treatment
0,240  0,021  Renal failure treatment
0,242  0,023  Aldehyde oxidase substrate
0,229  0,010  Carbonic anhydrase XIII inhibitor
0,230  0,012  Histone deacetylase class III inhibitor
0,222  0,005  Glycine transporter 2 inhibitor
0,243  0,027  Antipruritic
0,223  0,008  Vanilloid 1 agonist
0,316  0,101  Toll-Like receptor agonist
0,224  0,009  Aldehyde dehydrogenase substrate
0,219  0,006  Toll-Like receptor 2 agonist
0,221  0,008  Creatine kinase inhibitor
0,216  0,003  GABA B receptor antagonist
0,217  0,004  Acyl-CoA dehydrogenase inhibitor
0,241  0,029  UGT2B15 substrate
0,212  0,005  Heat shock protein 70 antagonist
0,210  0,003  Glutamate (mGluR6) antagonist
0,212  0,005  NAT1 substrate
0,210  0,007  Inducible nitric-oxide synthase inhibitor
0,217  0,014  Cyclooxygenase 3 inhibitor
0,208  0,005  GST T1-1 substrate
0,244  0,040  Diabetic retinopathy treatment
0,267  0,064  Antiamyloidogenic
0,206  0,004  Antifungal (Pneumocystis)
0,207  0,004  Restless leg syndrome treatment
0,206  0,004  Sphingosine 1-phosphate receptor 4 agonist
0,214  0,012  Growth stimulant
0,249  0,047  DNA methyltransferase I inhibitor
0,219  0,018  Arachidonic acid antagonist
0,227  0,026  VEGF expression inhibitor
0,250  0,049  RNA-directed DNA polymerase inhibitor
0,220  0,020  GABA C receptor rho-2 antagonist
0,205  0,005  Antidote, mercury
0,252  0,052  Chemopreventive
0,209  0,010  HIV-1 integrase (Overall Integration) inhibitor
0,271  0,073  Transcription factor STAT inhibitor
0,210  0,014  UGT2B1 substrate
0,205  0,010  Chronic obstructive bronchitis treatment
0,237  0,042  Nitric-oxide synthase stimulant
0,269  0,074  Antioxidant
0,195  0,002  GABA transporter 3 inhibitor
0,202  0,009  Nitric-oxide synthase inhibitor
0,216  0,026  Aldose reductase substrate
0,193  0,003  AMPA 3 receptor antagonist
0,192  0,003  Antiviral (Parainfluenza)
0,195  0,007  Neurotensin receptor antagonist
0,216  0,030  Antidiabetic (type 1)
0,195  0,011  CXC chemokine 4 receptor antagonist
0,195  0,010  Actinic keratosis treatment
0,193  0,010  Cell adhesion molecule inhibitor
0,187  0,005  NMDA 2A receptor antagonist
0,191  0,010  Sphingosine 1-phosphate receptor 2 antagonist
0,213  0,033  UGT2B9 substrate
0,321  0,140  Calcium channel L-type activator
0,202  0,024  Cystathionine beta-synthase inhibitor
0,182  0,006  Ca2+-transporting ATPase inhibitor
0,184  0,009  DOPA decarboxylase inhibitor
0,218  0,043  Antihelmintic (Nematodes)
0,183  0,008  Somatostatin 1 agonist
0,244  0,070  Hypolipemic
0,202  0,028  DNA polymerase I inhibitor
0,197  0,023  Cathepsin H inhibitor
0,173  0,002  Arginase inhibitor
0,208  0,038  Interferon gamma antagonist
0,188  0,018  Sphingosine 1-phosphate receptor 5 antagonist
0,210  0,041  Restenosis treatment
0,202  0,033  Death-associated protein kinase 2 inhibitor
0,185  0,017  Cathepsin G inhibitor
0,328  0,160  Antineoplastic (solid tumors)
0,174  0,007  Carbonic anhydrase VB inhibitor
0,169  0,003  GABA transporter 2 inhibitor
0,179  0,013  Antiviral (Papilloma)
0,176  0,010  Interleukin 1 beta converting enzyme inhibitor
0,189  0,024  Movement disorders treatment
0,186  0,021  Anticataract
0,167  0,004  Mannosidase inhibitor
0,167  0,004  Integrin beta3 antagonist
0,201  0,039  Thiol protease inhibitor
0,166  0,003  Glutamate (mGluR4) antagonist
0,199  0,037  Phobic disorders treatment
0,202  0,040  Melanin inhibitor
0,176  0,014  Selectin antagonist
0,180  0,018  Mediator release inhibitor
0,166  0,004  Kainate receptor antagonist
0,201  0,041  Acute respiratory distress syndrome (ARDS) treatment
0,184  0,025  Carcinogenic, group 2B
0,234  0,076  Free radical scavenger
0,163  0,005  Sphingosine 1-phosphate receptor 5 agonist
0,162  0,005  Kinesin antagonist
0,162  0,005  Kinesin-like protein 1 inhibitor
0,207  0,051  5 Hydroxytryptamine 3E antagonist
0,166  0,011  Carbonic anhydrase V inhibitor
0,158  0,004  AMPA 1 receptor antagonist
0,177  0,024  GABA receptor agonist
0,182  0,029  Antieczematic
0,245  0,093  Antineurogenic pain
0,222  0,070  Antihypertriglyceridemic
0,198  0,047  Prostate disorders treatment
0,241  0,090  Transcription factor STAT3 inhibitor
0,195  0,044  Antiischemic, cerebral
0,156  0,006  NMDA receptor subunit 3B antagonist
0,163  0,013  Factor V inhibitor
0,170  0,022  Sulfotransferase substrate
0,159  0,011  Antimetabolite
0,158  0,011  Tocolytic
0,163  0,017  Myasthenia Gravis treatment
0,187  0,041  Genotoxic
0,154  0,010  Lanosterol 14 alpha demethylase inhibitor
0,156  0,012  Histamine N-methyltransferase inhibitor
0,152  0,010  Carbonic anhydrase VA inhibitor
0,157  0,015  NMDA 2 receptor antagonist
0,168  0,028  Antischistosomal
0,167  0,028  Menstruation disorders treatment
0,178  0,039  Cocaine dependence treatment
0,146  0,007  Sirtuin 1 inhibitor
0,154  0,016  Anabolic
0,143  0,005  Leukotriene A4 hydrolase inhibitor
0,152  0,014  UGT2B11 substrate
0,156  0,019  Transcription factor STAT6 inhibitor
0,163  0,025  Contraceptive female
0,149  0,012  Glutathione S-transferase inhibitor
0,206  0,070  Neurotrophic factor enhancer
0,163  0,027  Alcohol dehydrogenase substrate
0,185  0,049  Acetylcholine M1 receptor antagonist
0,138  0,003  Glucose-6-phosphate isomerase inhibitor
0,148  0,013  Glutamate (mGluR7) agonist
0,180  0,046  Antidiarrheal
0,139  0,005  Interferon inducer
0,163  0,029  5 Hydroxytryptamine 3A agonist
0,156  0,024  Caspase 3 inhibitor
0,137  0,005  AMPA 2 receptor antagonist
0,145  0,013  Antileprosy
0,142  0,010  Prostaglandin EP2 antagonist
0,237  0,106  Antiepileptic
0,143  0,013  Antifungal (Candida)
0,140  0,010  Glycine receptor antagonist
0,134  0,004  Glutamate (mGluR group III) antagonist
0,155  0,025  Antiviral (Influenza B)
0,131  0,002  Glutamate (mGluR8) agonist
0,134  0,005  NMDA receptor glycine site agonist
0,132  0,003  SULT2A1 substrate
0,135  0,008  Anticholelithogenic
0,130  0,002  Membrane dipeptidase inhibitor
0,164  0,036  Antibacterial (Helicobacter pylori)
0,142  0,016  Keratolytic
0,129  0,004  Antidote, organophosphates
0,174  0,050  Anesthetic
0,145  0,024  Toll-Like receptor 4 antagonist
0,141  0,020  Thioredoxin inhibitor
0,197  0,076  Antiviral (Influenza)
0,129  0,008  Caspase 9 inhibitor
0,144  0,024  Carcinogenic, group 2A
0,126  0,005  Phosphoglycerate kinase inhibitor
0,126  0,006  Prostaglandin F2 alpha antagonist
0,130  0,009  Narcotic antagonist
0,123  0,003  Glutamate (mGluR1a) agonist
0,149  0,029  UDP-glucose 4-epimerase inhibitor
0,123  0,004  Anesthetic inhalation
0,164  0,046  Psychosexual dysfunction treatment
0,175  0,059  Protein-tyrosine phosphatase inhibitor
0,129  0,012  Hyperparathyroidism treatment
0,129  0,012  Glucagon-like peptide 1 agonist
0,148  0,033  DNA repair enzyme inhibitor
0,122  0,007  NMDA receptor subunit 3A antagonist
0,201  0,086  Antiparasitic
0,269  0,155  CYP2C19 inhibitor
0,147  0,033  Constipation treatment
0,133  0,020  Tourette's syndrome treatment
0,117  0,005  Alpha-mannosidase inhibitor
0,117  0,005  Complement C3a chemotactic receptor antagonist
0,133  0,021  Protein kinase B gamma inhibitor
0,147  0,036  Sphingosine 1-phosphate receptor 4 antagonist
0,128  0,017  Myeloperoxidase inhibitor
0,124  0,014  Na+ K+ transporting ATPase inhibitor
0,117  0,007  Phospholipase D inhibitor
0,125  0,016  Bile acid receptor antagonist
0,111  0,001  Carbonic anhydrase VIII inhibitor
0,111  0,001  Carbonic anhydrase X inhibitor
0,145  0,036  Choleretic
0,112  0,003  GABA uptake inhibitor
0,117  0,008  Hypercalcemia treatment
0,160  0,051  Neuropeptide Y1 antagonist
0,119  0,010  Estrogen-related receptor beta agonist
0,112  0,004  Vitronectin receptor antagonist
0,151  0,044  Cholesterol synthesis inhibitor
0,143  0,036  TRPA1 agonist
0,128  0,022  Transcription factor NF kappa B stimulant
0,162  0,056  Antiprotozoal (Coccidial)
0,252  0,146  Toll-Like receptor 7 agonist
0,119  0,014  Prostaglandin antagonist
0,161  0,056  Antiacne
0,121  0,017  Ribonucleotide reductase inhibitor
0,137  0,033  Potassium channel (Ca-activated) activator
0,106  0,005  Retinoid X alpha receptor agonist
0,188  0,086  Pneumotoxic
0,110  0,009  Plasminogen activator inhibitor antagonist
0,151  0,049  Antiprotozoal (Trichomonas)
0,105  0,004  Integrin alphaVbeta3 antagonist
0,139  0,038  Protein kinase C gamma inhibitor
0,105  0,004  Kainate receptor 2 antagonist
0,141  0,040  Antiprotozoal (Babesia)
0,106  0,005  Thromboxane synthase inhibitor
0,110  0,010  Vanilloid 4 agonist
0,148  0,049  Antihelmintic (Trematoda)
0,108  0,010  Erythropoietin receptor agonist
0,252  0,153  Antineoplastic (non-Hodgkin's lymphoma)
0,109  0,011  Uterine relaxant
0,107  0,008  CD45 antagonist
0,105  0,006  Somatostatin 2 antagonist
0,108  0,010  AMPA receptor antagonist
0,136  0,038  Antihelmintic (Fasciola)
0,106  0,009  MAP kinase kinase 7 inhibitor
0,162  0,065  Acaricide
0,152  0,056  Nav1.2 sodium channel blocker
0,105  0,010  S-adenosyl-L-methionine decarboxylase inhibitor
0,097  0,003  Kainate receptor agonist
0,115  0,021  Vanilloid agonist
0,103  0,010  Carbonic anhydrase XIV inhibitor
0,115  0,023  Antiprotozoal activity enhancer
0,109  0,018  Ribonucleoside-diphosphate reductase inhibitor
0,095  0,004  Kainate receptor 1 antagonist
0,093  0,002  Amino-acid-polyamine-organocation (APC) transporter antagonist
0,104  0,013  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,105  0,015  Maillard reaction inhibitor
0,098  0,007  Somatostatin 1 antagonist
0,119  0,029  Interleukin 12 antagonist
0,112  0,022  Granulocyte macrophage colony stimulating factor agonist
0,096  0,007  Somatostatin 5 antagonist
0,094  0,005  AICAR transformylase inhibitor
0,094  0,005  Somatostatin 5 agonist
0,118  0,030  ErbB-3 antagonist
0,096  0,008  Epithelial sodium channel blocker
0,091  0,004  Geranyltranstransferase inhibitor
0,092  0,006  Lysophosphatidic acid 3 receptor antagonist
0,095  0,009  MDM2 inhibitor
0,115  0,029  CYP2A6 inhibitor
0,091  0,005  Dihydropteroate synthase inhibitor
0,096  0,010  Glutamate (mGluR group III) agonist
0,095  0,010  Botulinum neurotoxin type A inhibitor
0,300  0,216  Antiinflammatory
0,089  0,005  Dopamine D5 agonist
0,154  0,070  CF transmembrane conductance regulator agonist
0,136  0,053  Gastritis treatment
0,136  0,052  Beta amyloid protein antagonist
0,153  0,069  Hearing loss treatment
0,088  0,005  Thymidylate synthase inhibitor
0,096  0,013  Thromboxane antagonist
0,088  0,006  Retinoid X receptor agonist
0,111  0,030  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,091  0,010  Corticotropin releasing factor 2 receptor antagonist
0,089  0,007  Sphingosine 1-phosphate receptor agonist
0,085  0,003  Carboxypeptidase B inhibitor
0,086  0,005  Neurokinin 2 agonist
0,097  0,017  Purinergic P2X1 antagonist
0,097  0,018  Trypsin inhibitor
0,141  0,062  Toll-Like receptor antagonist
0,105  0,026  Neuropeptide agonist
0,151  0,072  Antiviral (Influenza A)
0,130  0,051  Microtubule formation inhibitor
0,132  0,054  Monophenol monooxygenase inhibitor
0,088  0,011  Thromboxane A2 antagonist
0,088  0,011  Macrophage elastase inhibitor
0,093  0,015  Glutamate (mGluR7) antagonist
0,088  0,011  Calcitonin receptor agonist
0,103  0,026  D-Ala-D-Ala ligase inhibitor
0,101  0,025  Thrombin inhibitor
0,118  0,043  Sphingomyelinase inhibitor
0,081  0,006  Sphingosine 1-phosphate receptor 1 agonist
0,167  0,092  Antihelmintic
0,083  0,009  Growth hormone release inhibitor
0,137  0,063  Allergic rhinitis treatment
0,182  0,109  Cyclic AMP phosphodiesterase inhibitor
0,077  0,004  Sodium-dependent vitamin C transporter 2 inhibitor
0,119  0,047  Mental retardation treatment
0,081  0,009  Adenosine deaminase inhibitor
0,090  0,018  Gaucher disease treatment
0,081  0,009  Carbonic anhydrase II stimulant
0,091  0,019  Plasminogen activator inhibitor
0,075  0,004  Glutamate (mGluR1) agonist
0,074  0,003  Glutamate (mGluR3) agonist
0,083  0,012  Angiotensin-converting enzyme inhibitor
0,081  0,011  Carbonic anhydrase IV inhibitor
0,074  0,004  Excitatory amino acid transporter 2 inhibitor
0,090  0,020  Aminopeptidase microsomal inhibitor
0,103  0,033  Antibiotic
0,073  0,004  Glutamate (mGluR8) antagonist
0,103  0,035  Glutamate receptor agonist
0,075  0,008  Integrin alpha5beta1 antagonist
0,147  0,082  Hexokinase inhibitor
0,090  0,025  Antitreponemal
0,083  0,018  Antihemophilic
0,112  0,047  Antifibrinolytic
0,118  0,053  Neutropenia treatment
0,071  0,006  Dihydrofolate reductase inhibitor
0,071  0,006  Glucagon-like peptide 1 receptor antagonist
0,102  0,038  Acetylcholine nicotinic antagonist
0,069  0,005  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,071  0,008  Dopamine beta hydroxylase inhibitor
0,065  0,003  GRP78 expression inhibitor
0,106  0,043  Protein kinase C zeta inhibitor
0,080  0,017  Bombesin 2 receptor antagonist
0,115  0,053  AMP-activated protein kinase stimulant
0,066  0,004  Urotensin II agonist
0,159  0,097  Antineoplastic (bone cancer)
0,100  0,038  Factor XII inhibitor
0,094  0,032  Peroxisome proliferator-activated receptor gamma agonist
0,194  0,133  Antineoplastic (pancreatic cancer)
0,099  0,039  Metalloproteinase-2 inhibitor
0,069  0,009  Carbonic anhydrase I stimulant
0,229  0,170  Antiasthmatic
0,114  0,054  Antiprotozoal (Toxoplasma)
0,066  0,007  Guanylate cyclase inhibitor
0,069  0,009  Cholecystokinin B agonist
0,075  0,016  Sphingosine 1-phosphate receptor 1 antagonist
0,066  0,007  Somatostatin 4 antagonist
0,073  0,014  Ryanodine receptor antagonist
0,082  0,023  Exportin-1 inhibitor
0,060  0,002  Glutamate (mGluR6) agonist
0,080  0,022  Plasmin inhibitor
0,061  0,005  Calcium-sensing receptor agonist
0,060  0,004  N-Acetylated alpha-linked acidic dipeptidase inhibitor
0,125  0,069  Glutamate receptor antagonist
0,079  0,023  Nitric oxide donor
0,085  0,029  Neutrophil collagenase inhibitor
0,185  0,129  Calpain inhibitor
0,114  0,058  Falcipain 3 inhibitor
0,120  0,064  Antitussive
0,065  0,009  Neuraminidase (Influenza A) inhibitor
0,076  0,020  Sphingosine 1-phosphate receptor 3 antagonist
0,067  0,012  Oxytocin agonist
0,210  0,155  Caspase 3 stimulant
0,132  0,078  Nav1.6 sodium channel blocker
0,087  0,033  Leukotriene synthesis inhibitor
0,069  0,015  Leukotriene C antagonist
0,061  0,008  Glucagon receptor antagonist
0,151  0,099  ATPase inhibitor
0,062  0,010  Parathyroid hormone antagonist
0,063  0,011  Factor XIIIa inhibitor
0,058  0,006  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,131  0,079  Neurotrophic factor
0,118  0,067  Proteasome inhibitor
0,084  0,033  Premenstrual syndrome treatment
0,063  0,013  Histamine H2 receptor agonist
0,084  0,034  CXC chemokine receptor antagonist
0,070  0,020  Aminopeptidase N inhibitor
0,093  0,044  Topoisomerase II alpha inhibitor
0,116  0,066  Protein-tyrosine phosphatase 1B inhibitor
0,080  0,031  Endocannabinoid uptake inhibitor
0,061  0,012  Cytokine production stimulant
0,108  0,058  Urease inhibitor
0,121  0,072  Cholinergic antagonist
0,101  0,053  Posttraumatic stress disorder treatment
0,056  0,008  Dipeptidyl peptidase II inhibitor
0,132  0,083  Mannose-6-phosphate isomerase inhibitor
0,077  0,029  Protease 3C (Human rhinovirus) inhibitor
0,076  0,028  Neuraminidase (influenza) inhibitor
0,098  0,049  Opioid antagonist
0,075  0,027  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,076  0,028  Neuraminidase inhibitor
0,068  0,021  Leukotriene B4 antagonist
0,052  0,005  Tryptophan 5 hydroxylase inhibitor
0,153  0,106  LDLR expression enhancer
0,054  0,007  Prostaglandin D2 agonist
0,066  0,019  Pregnane X receptor antagonist
0,084  0,038  Sphingosine 1-phosphate receptor antagonist
0,075  0,029  Narcolepsy treatment
0,058  0,011  VLA-4 antagonist
0,055  0,008  Peptide deformylase inhibitor
0,050  0,004  Purinergic P2Y15 antagonist
0,050  0,004  Prostaglandin F2 alpha agonist
0,088  0,043  Macrophage migration inhibitory factor inhibitor
0,049  0,004  Lysophosphatidic acid receptor 1 agonist
0,054  0,008  Hypoxanthine phosphoribosyltransferase inhibitor
0,106  0,060  Protease inhibitor
0,116  0,071  Acetylcholine muscarinic antagonist
0,055  0,010  Tryptase inhibitor
0,048  0,003  GABA transporter inhibitor
0,054  0,010  Caspase 2 inhibitor
0,055  0,011  Prostacyclin antagonist
0,052  0,009  Endothelial nitric-oxide synthase inhibitor
0,051  0,008  Uridine phosphorylase inhibitor
0,050  0,007  Integrin alpha1beta1 antagonist
0,061  0,019  Purinergic P2Y antagonist
0,079  0,037  Opioid delta receptor antagonist
0,104  0,061  Gastric antisecretory
0,053  0,010  Integrin alpha2 antagonist
0,116  0,074  Acetylcholine antagonist
0,049  0,007  Kynurenine 3 monooxygenase inhibitor
0,054  0,012  Somatostatin agonist
0,054  0,012  Diamine oxidase inhibitor
0,067  0,025  Lipocortins synthesis agonist
0,187  0,146  5 Hydroxytryptamine 1E antagonist
0,113  0,072  Anesthetic local
0,071  0,030  Glutamate (mGluR1) antagonist
0,076  0,036  Protein kinase C beta inhibitor
0,045  0,004  Prostaglandin H2 antagonist
0,050  0,009  VCAM-1 antagonist
0,067  0,026  Beta 2 adrenoreceptor agonist
0,060  0,019  Cholecystokinin antagonist
0,050  0,009  VCAM antagonist
0,073  0,034  Beta adrenoreceptor antagonist
0,050  0,010  Cholesterol absorption inhibitor
0,058  0,019  Adenylate cyclase 1 inhibitor
0,051  0,012  Sirtuin 2 inhibitor
0,063  0,024  DNA helicase inhibitor
0,053  0,015  Histamine H1 receptor agonist
0,074  0,036  Leukotriene antagonist
0,136  0,098  Neuropathy treatment
0,070  0,032  Antimycoplasmal
0,043  0,006  Integrin beta5 antagonist
0,068  0,031  Histone deacetylase SIRT3 inhibitor
0,048  0,011  Glutamate (mGluR4) agonist
0,039  0,003  Carboxypeptidase B2 inhibitor
0,049  0,013  Retinoid X receptor antagonist
0,125  0,089  Lipid peroxidase inhibitor
0,038  0,002  Carbonic anhydrase XI inhibitor
0,161  0,125  Histone acetyltransferase inhibitor
0,064  0,029  Matrix metalloproteinase (membrane-type) inhibitor
0,043  0,007  LFA antagonist
0,059  0,024  Antibiotic Glycopeptide-like
0,051  0,016  Sphingosine 1-phosphate receptor 3 agonist
0,062  0,027  Urokinase inhibitor
0,059  0,025  Beta 2 adrenoreceptor antagonist
0,040  0,006  Thyroid hormone agonist
0,039  0,005  Aminopeptidase A inhibitor
0,066  0,032  Potassium channel intermediate-conductance Ca-activated blocker
0,045  0,012  Integrin alpha4 antagonist
0,187  0,154  Lipoxygenase inhibitor
0,036  0,003  Thromboxane A2 agonist
0,051  0,018  Thymidine kinase inhibitor
0,058  0,026  Heparanase inhibitor
0,047  0,015  Antibiotic Aminoglycoside-like
0,062  0,030  Postcoital contraceptive
0,036  0,005  Vanilloid 2 agonist
0,035  0,004  Excitatory amino acid transporter 3 inhibitor
0,073  0,042  Matrix metalloproteinase inhibitor
0,040  0,009  Prostaglandin EP2 agonist
0,058  0,027  Diacylglycerol O-acyltransferase inhibitor
0,045  0,015  Leukotriene C4 antagonist
0,040  0,010  Growth hormone releasing factor antagonist
0,039  0,009  Purinergic P2Y12 antagonist
0,100  0,070  Topoisomerase I inhibitor
0,035  0,005  Integrin alphaVbeta1 antagonist
0,087  0,057  Calcium antagonist
0,083  0,054  Adrenaline agonist
0,039  0,010  NMDA 2D receptor antagonist
0,063  0,034  Sphingosine kinase inhibitor
0,044  0,015  Trypsin I inhibitor
0,073  0,044  Opioid mu receptor antagonist
0,055  0,026  HCV NS3/NS4A protease inhibitor
0,041  0,012  ATP citrate lysase inhibitor
0,033  0,005  Prostacyclin agonist
0,055  0,027  Squalene epoxidase inhibitor
0,168  0,140  Heart failure treatment
0,040  0,013  Lysophosphatidic acid 2 receptor antagonist
0,041  0,014  Retinoid X alpha receptor antagonist
0,055  0,028  Metalloproteinase-3 inhibitor
0,162  0,136  Antiviral (HIV)
0,040  0,014  Prostaglandin agonist
0,114  0,088  Antismoking
0,039  0,013  Methionyl aminopeptidase 1 inhibitor
0,030  0,004  Excitatory amino acid transporter 1 inhibitor
0,046  0,021  Cholecystokinin A antagonist
0,038  0,012  Thrombin receptor antagonist
0,034  0,009  Somatostatin 3 antagonist
0,030  0,004  Retinoid X beta receptor antagonist
0,029  0,005  Toll-Like receptor 8 agonist
0,173  0,148  Cardiotonic
0,028  0,003  Methylmalonyl-CoA mutase inhibitor
0,060  0,036  Beta 1 adrenoreceptor antagonist
0,026  0,002  Folate transporter 1 inhibitor
0,039  0,015  Factor VII inhibitor
0,069  0,045  Potassium channel large-conductance Ca-activated activator
0,028  0,004  Lysophosphatidic acid receptor 3 agonist
0,136  0,112  Antiviral (Hepatitis C)
0,182  0,158  Renal disease treatment
0,073  0,050  Metalloproteinase-9 inhibitor
0,052  0,029  Antiviral (Herpesvirus 3, Human)
0,028  0,005  Neuraminidase (Influenza B) inhibitor
0,029  0,006  Isoleucine-tRNA ligase inhibitor
0,051  0,029  Phosphorylase inhibitor
0,065  0,043  Beta 3 adrenoreceptor antagonist
0,036  0,014  Leukotriene B4 receptor 1 antagonist
0,033  0,012  Kainate receptor 4 antagonist
0,072  0,051  Epoxide hydrolase inhibitor
0,054  0,034  Dipeptidyl peptidase inhibitor
0,047  0,027  Nicotinic receptor alpha3 subunit antagonist
0,075  0,055  NAD(P)H dehydrogenase (quinone) inhibitor
0,097  0,077  DNA intercalator
0,023  0,004  Integrin alphaVbeta5 antagonist
0,045  0,026  Nerve growth factor antagonist
0,025  0,006  Ileal bile acid transport inhibitor
0,032  0,013  Vasopressin 1A agonist
0,094  0,075  Gout treatment
0,037  0,019  Free fatty acid receptor 1 antagonist
0,022  0,004  GABA transporter 1 inhibitor
0,034  0,016  Epoxide hydrolase 1 inhibitor
0,023  0,005  Integrin alphaVbeta6 antagonist
0,024  0,006  Antibiotic Anthracycline-like
0,043  0,025  Plasmepsin II inhibitor
0,025  0,008  Free fatty acid receptor 1 agonist
0,037  0,019  HMG CoA reductase inhibitor
0,102  0,084  Topoisomerase II inhibitor
0,182  0,164  Antineoplastic (bladder cancer)
0,033  0,016  Bradykinin B2 receptor agonist
0,030  0,013  Retinoid X gamma receptor antagonist
0,021  0,004  Integrin beta6 antagonist
0,114  0,097  Skin whitener
0,030  0,013  Integrin alpha2beta1 antagonist
0,095  0,078  HDL-cholesterol increasing
0,024  0,008  Caspase 8 inhibitor
0,055  0,039  Adenine nucleotide translocase inhibitor
0,020  0,004  Thromboxane agonist
0,026  0,010  Monocarboxylic acid transporter 1 inhibitor
0,026  0,010  Monocarboxylic acid transporter inhibitor
0,028  0,012  Prostaglandin D2 antagonist
0,027  0,012  Retinoid X gamma receptor agonist
0,034  0,018  Cholecystokinin B antagonist
0,026  0,011  Kainate receptor 5 antagonist
0,029  0,014  Hedgehog signaling activator
0,025  0,010  Lysophosphatidic acid 1 receptor antagonist
0,080  0,065  Antiviral (Dengue virus)
0,045  0,031  Fructose-1,6-bisphosphatase inhibitor
0,101  0,086  Acetylcholine release stimulant
0,030  0,015  Baculoviral IAP repeat-containing protein 4 inhibitor
0,021  0,007  Telomerase stimulant
0,027  0,013  Purinergic P2T antagonist
0,020  0,006  CXC chemokine 4 receptor agonist
0,054  0,040  Immunoglobulin Fc receptor antagonist
0,042  0,029  Angiotensin AT1 receptor antagonist
0,047  0,033  Endothelin-converting enzyme inhibitor
0,036  0,023  AMPA receptor agonist
0,107  0,094  Antiprotozoal (Amoeba)
0,069  0,056  Peroxisome proliferator-activated receptor gamma antagonist
0,024  0,012  Neurokinin 1 agonist
0,076  0,064  Protein kinase A inhibitor
0,051  0,039  Histamine agonist
0,046  0,034  Melanocortin antagonist
0,087  0,076  Xanthine oxidase inhibitor
0,025  0,014  Prostaglandin E2 agonist
0,074  0,063  Chymotrypsin inhibitor
0,034  0,023  Calcium-independent phospholipase A2 inhibitor
0,014  0,002  Integrin alpha5beta6 antagonist
0,024  0,013  ICAM 1 antagonist
0,094  0,084  Rhinitis treatment
0,020  0,009  Kainate receptor 3 antagonist
0,044  0,034  Beta adrenoreceptor agonist
0,056  0,046  Cyclin A1 inhibitor
0,029  0,019  1,3-Beta-glucan synthase inhibitor
0,034  0,024  Angiotensin II receptor antagonist
0,017  0,007  Sodium/hydrogen exchanger 3 inhibitor
0,052  0,043  Sphingosine kinase 2 inhibitor
0,033  0,024  Peroxisome proliferator-activated receptor delta antagonist
0,018  0,009  Tryptophan hydroxylase 1 inhibitor
0,043  0,034  Dipeptidyl peptidase IV inhibitor
0,011  0,002  P2 nucleoside transporter inhibitor
0,015  0,006  Calcium-dependent phospholipase A2 inhibitor
0,078  0,069  Histamine H2 receptor antagonist
0,110  0,101  Interleukin 4 antagonist
0,012  0,003  Phosphoribosylglycinamide formyltransferase inhibitor
0,025  0,017  Complement factor 1s inhibitor
0,018  0,009  Prostaglandin EP4 agonist
0,018  0,010  G-protein-coupled receptor 120 agonist
0,022  0,014  Retinoid X beta receptor agonist
0,112  0,104  Cachexia treatment
0,017  0,010  Vitamin D receptor agonist
0,035  0,028  5-Alpha-reductase inhibitor
0,061  0,053  Neuronal nicotinic receptor antagonist
0,028  0,021  Estrogen-related receptor gamma antagonist
0,026  0,018  Prostaglandin EP4 antagonist
0,077  0,070  Sleep apnea treatment
0,012  0,005  Excitatory amino acid transporter 4 inhibitor
0,044  0,037  Peroxisome proliferator-activated receptor alpha agonist
0,034  0,027  Growth factor receptor-bound protein 2 antagonist
0,047  0,041  Prolyl endopeptidase inhibitor
0,034  0,027  p53 inhibitor
0,076  0,070  Caspase 7 inhibitor
0,035  0,029  Factor VIIa inhibitor
0,018  0,011  Vesicular glutamate transport inhibitor
0,019  0,013  Cholecystokinin agonist
0,042  0,037  Opioid mu receptor agonist
0,036  0,031  Urate transporter 1 inhibitor
0,038  0,033  Melanocortin 4 antagonist
0,014  0,010  Somatostatin 2 agonist
0,170  0,166  Amyotrophic lateral sclerosis treatment
0,016  0,012  Cholecystokinin A agonist
0,009  0,005  Free fatty acid receptor 2 antagonist
0,033  0,029  Ceramide glucosyltransferase inhibitor
0,015  0,011  Purinergic P2Y1 agonist
0,018  0,014  Estrogen-related receptor gamma agonist
0,019  0,016  Neutral endopeptidase inhibitor
0,011  0,008  Neurokinin 3 agonist
0,016  0,012  Thyroid hormone alpha agonist
0,018  0,015  5-Alpha-reductase 2 inhibitor
0,090  0,087  Protein kinase (CK2) alpha inhibitor
0,030  0,028  Peroxisome proliferator-activated receptor delta agonist
0,033  0,031  Melanocortin 1 antagonist
0,022  0,020  Protein 30S ribosomal subunit inhibitor
0,032  0,030  HCV polyprotein inhibitor
0,029  0,026  Caspase 6 inhibitor
0,013  0,011  Glucagon agonist
0,019  0,017  Antibiotic Quinolone-like
0,040  0,038  Guanylate cyclase stimulant
0,012  0,011  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,046  0,045  Factor III inhibitor
0,060  0,060  Protein kinase C alpha inhibitor
0,017  0,017  Integrin beta7 antagonist
0,013  0,013  Adenosine A2a receptor agonist

